Compare WGS & MC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WGS | MC |
|---|---|---|
| Founded | 2017 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Investment Managers |
| Sector | Technology | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 4.6B |
| IPO Year | N/A | 2014 |
| Metric | WGS | MC |
|---|---|---|
| Price | $158.77 | $68.68 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 9 |
| Target Price | ★ $130.63 | $72.75 |
| AVG Volume (30 Days) | 490.6K | ★ 808.4K |
| Earning Date | 10-28-2025 | 10-29-2025 |
| Dividend Yield | N/A | ★ 3.79% |
| EPS Growth | N/A | ★ 446.16 |
| EPS | 0.07 | ★ 3.17 |
| Revenue | $402,190,000.00 | ★ $1,467,580,000.00 |
| Revenue This Year | $41.17 | $27.25 |
| Revenue Next Year | $23.53 | $17.11 |
| P/E Ratio | $2,205.80 | ★ $21.67 |
| Revenue Growth | 50.50 | ★ 51.19 |
| 52 Week Low | $55.17 | $47.00 |
| 52 Week High | $170.87 | $82.89 |
| Indicator | WGS | MC |
|---|---|---|
| Relative Strength Index (RSI) | 62.52 | 63.90 |
| Support Level | $158.15 | $62.77 |
| Resistance Level | $170.87 | $65.16 |
| Average True Range (ATR) | 8.35 | 1.97 |
| MACD | 0.80 | 0.80 |
| Stochastic Oscillator | 72.69 | 91.95 |
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.
Moelis & Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.